Unknown

Dataset Information

Efficacy of stereotactic body radiation therapy for locoregional recurrent pancreatic cancer after radical resection.


ABSTRACT:

Objective

This study aimed to analyze the efficacy and toxicity of stereotactic body radiotherapy (SBRT) for locoregional recurrent pancreatic cancer after radical resection.

Methods

Patients with locoregional recurrent pancreatic cancer after surgery treated with SBRT in our institution were retrospectively investigated from January 2010 to January 2020. Absolute neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) recorded at pretreatment were analyzed. Endpoints included overall survival (OS), progression-free survival (PFS) and cumulative incidences of local failure (LF) and metastatic failure (MF).

Results

A total of 22 patients received SBRT with a median prescribed dose of 40 Gy (range of 30-50 Gy)/4 to 7 fractions. The median OS of all p

SUBMITTER: Ji X 

PROVIDER: S-EPMC9353056 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature